The HealthTree News for AML is a place to learn all about AML in easy-to-understand language. The site features news articles, patient stories, AML basics articles, and clinical trial updates with new content every week.
Feb. 01, 2023
Childhood AML - Learn About the Basics
Jan. 30, 2023
ASH 2022: Root Causes of Health Inequity
Jan. 25, 2023
ASH 2022: New Therapies in AML with Dr. Stein
Jan. 19, 2023
ASH 2022: Determining Who Does Well on Venetoclax and Azacitidine in Newly Diagnosed AML with Dr. Pollyea
Jan. 12, 2023
ASH 2022: An Individualized Approach to Treating AML Patients with Dr. Becker
Jan. 04, 2023
ASH 2022: Is a Restrictive Diet Necessary Post Stem Cell Transplant?
Jan. 01, 2023
What AML Taught Me in 2022
Dec. 29, 2022
ASH 2022: A New Venetoclax Combination Therapy for Untreated AML and High-Risk MDS
Dec. 19, 2022
ASH 2022: Treatment vs Quality of Life in Older AML Patients
Dec. 19, 2022
ASH 2022: Complete Response Criteria in Pediatric AML Needs Updating
Dec. 14, 2022
ASH 2022: Revumenib Leads to Long-Lasting Responses in KMT2Ar(MLLr) and NPM1-Mutated AML
Dec. 12, 2022
ASH 2022: Final Results of the VIALE-A Trial Assessing Venetoclax Plus Azacitidine
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.